Navigation Links
Mutant Kras drives pancreatic cancer maintenance via metabolic pathways
Date:4/26/2012

HOUSTON - A genetic mutation that drives the initiation of pancreatic cancer also manipulates metabolic pathways to support tumor growth and progression, scientists report in the journal Cell.

This newly discovered role for the Kras oncogene opens up a new category of potential targets for thwarting the influential mutation, which has proved difficult to attack directly, said study co-lead author Haoqiang Ying, Ph.D., instructor in The University of Texas MD Anderson Cancer Center Department of Genomic Medicine.

Pancreatic ductal adenocarcinoma has a five-year survival rate of about 5 percent. The National Cancer Institute estimates 43,920 new cases will be diagnosed in 2012 and 37,390 patients will die of the disease.

"Our research provides an additional metabolism angle to the search for therapeutic targets," Ying said. "The highly coordinated regulation of anabolic glucose metabolism by the Kras oncogene also indicates the need to develop combination strategies to target those pathways as well as other functional components of Kras signaling."

The Kras gene produces a protein that's influential in normal cell signaling. Mutated versions of Kras get stuck in a state of permanent activation and are so tightly bound to the enzyme GTP that small-molecule inhibitors have so far been unable to successfully target it, Ying said.

Cancer initiator also fuels growth and progression

"Activating mutations in the Kras oncogene are nearly universal in pancreatic cancers and have been shown to be important in the initiation of these cancers," said study senior author Ronald DePinho, M.D., president of MD Anderson. "The role of this critical gene in the maintenance of these tumors in an in vivo setting had not been explored."

To address this question, DePinho's team at Harvard Medical School and Dana-Farber Cancer Institute, where this research originated, developed an inducible Kras transgene (iKr
'/>"/>

Contact: Scott Merville
smerville@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Mutant gene identified that causes abnormal chromosome count, leading to cancer
2. Improved method for detecting mutant DNAs
3. Mutant Gene That Ups Risk for Ovarian Cancer May Aid Survival
4. Ganetespib showed activity in KRAS-mutant NSCLC as monotherapy and in combinations
5. Grassroots Campaign Drives toward Ending Malaria Deaths by 2015
6. Convenience drives US women to buy over-the-counter contraception in Mexico, study finds
7. Defensive Medicine Drives Wedge Between Patients/Physicians
8. Porsche Drives for Hope
9. Strength Based on Science Drives Glidewell Dental Lab's BruxZir Solid Zirconia
10. Researchers find pathway that drives spread of pediatric bone cancer in preclinical studies
11. Drug Targets Faulty Process That Drives Cystic Fibrosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... ... June 30, 2015 , ... Earlier this month Wound Care ... Course. Clinicians from WCA partnering hospitals across the country, met in Anaheim, California ... and hyperbaric medicine education and training is something that is never complete. Even ...
(Date:6/30/2015)... CA (PRWEB) , ... June 30, 2015 , ... ... its new YouTube video, “Fireside Convalescent Care Center.” The video informs community members ... video after continually seeing the need for those seeking care to be well ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... premier event and tradeshow, taking place July 29 to August 1. Retail Management ... , ThoughtSpot is a four-day event for independent community pharmacies, where ...
(Date:6/30/2015)... , ... June 30, 2015 , ... According to a ... 2007 to 2013 while heroin-related deaths more than tripled in the same period—leading a ... Novus Medical Detox Center , a leading Florida-based drug treatment facility, asserts that ...
(Date:6/30/2015)... ... June 30, 2015 , ... According to a June ... $3.1 million grant to study how sensory stimuli can be used to “decrease children’s ... improving care for children with autism, will compare patient experience in a “typical dental ...
Breaking Medicine News(10 mins):Health News:Wound Care Advantage Hosts Its First UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 2Health News:Wound Care Advantage Hosts Its First UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 3Health News:Fireside Convalescent Hospital Proves Itself as a Leading Care Center in New Video 2Health News:Retail Management Solutions to Attend Amerisource's ThoughtSpot 2015 Conference and Trade Show 2Health News:Retail Management Solutions to Attend Amerisource's ThoughtSpot 2015 Conference and Trade Show 3Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 2Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 3Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 4Health News:New Study Aims to Determine if Sensory Stimuli can Ease Dental Anxiety in Children, Notes Medical Center Dental Care 2Health News:New Study Aims to Determine if Sensory Stimuli can Ease Dental Anxiety in Children, Notes Medical Center Dental Care 3
... Successfully treating and reversing the effects of multiple sclerosis, ... drug originally developed to treat chronic pain, according to ... at Boulder. Watkins and her colleagues in CU-Boulder,s ... injection of a compound called ATL313 -- an anti-inflammatory ...
... Taking time off from certain osteoporosis drugs may be beneficial ... University Health System. Researchers found that bone density remained stable ... from bisphosphonates, a popular class of osteoporosis drugs that can ... the jaw bone. "These drugs are potentially harmful when ...
... at the Harvard School of Public Health (HSPH) and Knowledge ... or cancer believe the economic downturn is hurting their health ... Many Americans with these illnesses face financial problems paying for ... do not believe the new national health care reform law ...
... 18 (HealthDay News) -- A brain area that plays an ... separately to different colors, a new animal study has found. ... could help improve understanding of perception and attention, said the ... "In vision, objects are defined by both their shape ...
... By Steven Reinberg HealthDay Reporter , WEDNESDAY, Nov. ... as an example, new research finds that doctors, prescribing patterns ... from the U.S. Food and Drug Administration. The ... of risk depending on where they live, the researchers said. ...
... D receptors on cancer cells has prompted encouraging responses ... men with prostate cancer that has become resistant to ... clinical trial will be presented at the 22nd EORTC-NCI-AACR ... Berlin today (Thursday). The trial found that when the ...
Cached Medicine News:Health News:Laboratory studies show promise for new multiple sclerosis treatment 2Health News:Taking a break from osteoporosis drugs can protect bones 2Health News:Economic downturn takes toll on health of Americans with heart disease, diabetes or cancer 2Health News:Economic downturn takes toll on health of Americans with heart disease, diabetes or cancer 3Health News:Economic downturn takes toll on health of Americans with heart disease, diabetes or cancer 4Health News:Despite FDA Warning, Avandia Use Varies Across U.S. 2Health News:Despite FDA Warning, Avandia Use Varies Across U.S. 3Health News:New drug targets vitamin D receptors in hormone resistant prostate cancers 2Health News:New drug targets vitamin D receptors in hormone resistant prostate cancers 3
(Date:6/30/2015)... June 30, 2015   Millar, Inc. , a ... announced the 2016 retirement of Craig Thummel , ... 12 years of service to the Company. The Company ... senior members of the Executive Management team as his ... Daugherty , currently Director of Sales and Marketing, as ...
(Date:6/30/2015)... NEW YORK , June 30, 2015 /PRNewswire/ ... a late stage pharmaceutical company focused on the ... today announced the closing of its previously announced ... stock. The underwriters also exercised their over-allotment option ... of common stock. The net proceeds ...
(Date:6/30/2015)... June 24, 2015 ... addition of the "Global Array Instruments Market ... The global array instruments market to grow at ... 2014-2019 The global array instruments market can ... microarrays, and others including tissue microarrays and cell ...
Breaking Medicine Technology:Millar, Inc. Announces Leadership Changes 2Millar, Inc. Announces Leadership Changes 3Dipexium Announces Closing of Public Offering of Common Stock 2Dipexium Announces Closing of Public Offering of Common Stock 3Global Array Instruments Market 2015-2019 - Advances in Personalized Medicines with Affymetrix, Agilent Technologies & Illumina Dominating 2
... Roche announced today the opening of a new ... Nutley, N.J. The Roche Center of Excellence produces dosage ... and Phase 1 and 2 clinical studies. The 17,000 ... compounds into medicines for clinical trials. ...
... Sept. 30, 2011 The CyberKnife Coalition ... the CyberKnife Robotic Radiosurgery System® have now been enrolled ... track prostate cancer patients treated with stereotactic ... Radiosurgery (RPCR), tracks clinical and functional outcomes of men ...
Cached Medicine Technology:Roche Opens New Center of Excellence Facility 2First Prostate Cancer Registry for Robotic Radiosurgery Patients Enrolls More than 500 Men 2
... scaleable device that works with ... plasma or buffy coat. The ... must be prepared independently using ... volume and concentration factor can ...
Avitene Microfibrillar Collagen (MCH) is used in surgical procedures as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical....
The Ultrafoam Collagen Sponge is indicated in all surgical procedures as an adjunct to hemostasis when control by ligature or conventional procedures are ineffective or impractical....
Exclusive oxidized regenerated cellulose technology. The only oxidized regenerated cellulose hemostat line, surgicel absorbable hemostat delivers a unique combination of effectiveness, absorbability,...
Medicine Products: